Evidence map›Paper›PMID 41171728›Full record

ArticleThe journal of physical chemistry. B2025

Zahid Siraj, Anthony F Petrilla, Ishani M Senanayake, Nadiya Iqbal, Joseph N Gyesi, Jasilyn Westerfield, Praveen J Daluwathumullagamage, Roman V Shchepin, Sudarshan Ragunathan, Eduard Y Chekmenev and 1 more

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zahid SirajSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.
Anthony F PetrillaSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.
Ishani M SenanayakeSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.ORCID 0009-0003-4772-2983
Nadiya IqbalSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.
Joseph N GyesiDepartment of Chemistry, Karmanos Cancer Institute (KCI), Integrative Biosciences (Ibio), Wayne State University, Detroit, Michigan 48202, United States.
Jasilyn WesterfieldSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.
Praveen J DaluwathumullagamageSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.
Roman V ShchepinDepartment of Chemistry, South Dakota School of Mines & Technology (SDSM&T), Rapid City, South Dakota 57701, United States.
Sudarshan RagunathanHyperfine Inc., Guilford, Connecticut 06437, United States.
Eduard Y ChekmenevDepartment of Chemistry, Karmanos Cancer Institute (KCI), Integrative Biosciences (Ibio), Wayne State University, Detroit, Michigan 48202, United States.ORCID 0000-0002-8745-8801
Boyd M GoodsonSchool of Chemical & Biomolecular Sciences, Southern Illinois University, Carbondale, Illinois 62901, United States.ORCID 0000-0001-6079-5077

Funding

Rapid low-cost production of contrast agents for metabolic imagingR21EB033872 · NIBIB · WAYNE STATE UNIVERSITY · PI CHEKMENEV, EDUARD · 2023 to 2024
$415k
NIBIB NIH HHS R21 EB033872
6 · The paper itself

Abstract

Pyrazinamide (PZA), an FDA-approved antibiotic, was investigated for potential use as a hyperpolarized MRI contrast agent. PZA was readily hyperpolarized via parahydrogen-based NMR Signal Amplification By Reversible Exchange (SABRE) at ∼5.5 mT, allowing

Indexed as

Anti-Bacterial AgentsContrast MediaMagnetic Resonance ImagingPyrazinamideMagnetic Resonance SpectroscopyNitrogen IsotopesAnti-Bacterial AgentsContrast MediaNitrogen-15Nitrogen IsotopesPyrazinamide

Identifiers

PMID41171728
PMCPMC12623066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.